This study summarizes our initial efforts to address an issue that is critical to the success of any multicenter gene therapy clinical trial – maintenance of vector viability during shipping and ...

Drug efficacy and patient experience are given high precedence during the development of injectable biotherapeutics. To improve drug activity and efficacy, biotherapeutics are delivered subcutaneously ...